Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

42.9%

3 terminated/withdrawn out of 7 trials

Success Rate

57.1%

-29.4% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 3

1(20.0%)

Phase 4

1(20.0%)

5Total

N/A(3)

Phase 3(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT04188431Phase 4Terminated

Dexamethasone and Postoperative Bleeding Following Tonsillectomy in Children

Role: lead

NCT02986269Not ApplicableCompleted

PSV on Ventilation Inhomogeneity and Lung Function in Patients Under SB Across LMA

Role: lead

NCT03151863Phase 3Terminated

Intranasal Dexmedetomidine for Procedural Pain Management in Elderly Adults in Palliative Care

Role: lead

NCT04359407Completed

Prone Positioning and Regional Ventilation in Mechanically Ventilated COVID-19 Patients

Role: lead

NCT02384616Not ApplicableCompleted

Hyperoxygenation in Anesthetized Children

Role: lead

NCT02429154Not ApplicableCompleted

Assessment of Cerebral Vasoreactivity Using Near-infrared Spectroscopy (NIRS) in Infants (VARO)

Role: lead

NCT02714556Withdrawn

Changes in Ventilation Inhomogeneity and Respiratory Function Following Elective Caesarean Section Under Regional Anaesthesia

Role: lead

All 7 trials loaded